It was previously shown that TNF/TGFβ treatment of mouse mammary carcinoma cells induced EMT and generated breast cancer stem cells with a claudin-low molecular subtype characterized by the expression of mesenchymal and stem cell-associated markers, and associated with a poor prognosis [33]. The gene discussed is TGFB1; the disease is breast carcinoma.